These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 34222055)

  • 1. Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review.
    Sharifi Y; Payab M; Mohammadi-Vajari E; Aghili SMM; Sharifi F; Mehrdad N; Kashani E; Shadman Z; Larijani B; Ebrahimpur M
    J Diabetes Metab Disord; 2021 Dec; 20(2):1743-1765. PubMed ID: 34222055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study.
    Chen Q; Wang L; Li C; Hu W; Fan Y; Chen Z; Wu L; Lu Z; Ye J; Chen S; Tong J; Ruan L; Mei J; Lu H
    J Am Heart Assoc; 2021 Jun; 10(12):e018451. PubMed ID: 34096317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review.
    Ferguson M; Vel J; Phan V; Ali R; Mabe L; Cherner A; Doan T; Manakatt B; Jose M; Powell AR; McKinney K; Serag H; Sallam HS
    Metab Syndr Relat Disord; 2023 May; 21(4):177-187. PubMed ID: 37130311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus Disease 2019 and Cardiometabolic Disease.
    Kim CW; Aronow WS; Frishman WH
    Cardiol Rev; 2022 May-Jun 01; 30(3):123-128. PubMed ID: 34224449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
    Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
    Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study.
    Íñiguez M; Pérez-Matute P; Villoslada-Blanco P; Recio-Fernandez E; Ezquerro-Pérez D; Alba J; Ferreira-Laso ML; Oteo JA
    Front Endocrinol (Lausanne); 2021; 12():688071. PubMed ID: 34489863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.
    Buscemi S; Corleo D; Randazzo C
    Adv Exp Med Biol; 2021; 1353():115-129. PubMed ID: 35137371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between body mass index and cardio-metabolic risk factors among subjects in Wuhan, China: A cross-sectional study.
    Zhang S; Huang F; Xu R; Cheng A; Wan Z; Lv Y; Liu Q
    Medicine (Baltimore); 2021 Feb; 100(5):e23371. PubMed ID: 33592823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
    Pugliese G; Vitale M; Resi V; Orsi E
    Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study.
    Zhang Y; Cui Y; Shen M; Zhang J; Liu B; Dai M; Chen L; Han D; Fan Y; Zeng Y; Li W; Lin F; Li S; Chen X; Pan P;
    Diabetes Res Clin Pract; 2020 Jul; 165():108227. PubMed ID: 32446795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid-19 & Obesity: Beyond Bmi.
    Nadolsky KZ; Hurley DL; Garvey WT
    Endocr Pract; 2020 Aug; 26(8):923-925. PubMed ID: 33471684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
    Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken.
    Alberti A; Schuelter-Trevisol F; Iser BPM; Traebert E; Freiberger V; Ventura L; Rezin GT; da Silva BB; Meneghetti Dallacosta F; Grigollo L; Dias P; Fin G; De Jesus JA; Pertille F; Rossoni C; Hur Soares B; Nodari Júnior RJ; Comim CM
    World J Clin Cases; 2021 Jul; 9(20):5358-5371. PubMed ID: 34307590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Metabolic Syndrome on Severity of COVID-19 Illness.
    Wu S; Zhou K; Misra-Hebert A; Bena J; Kashyap SR
    Metab Syndr Relat Disord; 2022 May; 20(4):191-198. PubMed ID: 34995147
    [No Abstract]   [Full Text] [Related]  

  • 20. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
    Shah H; Khan MSH; Dhurandhar NV; Hegde V
    Acta Diabetol; 2021 Jul; 58(7):831-843. PubMed ID: 33587177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.